2011
DOI: 10.1016/j.lfs.2011.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 35 publications
(74 reference statements)
0
3
0
Order By: Relevance
“…Prostaglandin D2 can inhibit the development of gastric cancer [40]. Leukotriene D4 can aggravate gastric contraction and promote gastric acid secretion [41,42]. However, gastric pH increases during GPL and gastric cancer [43].…”
Section: Gc-tof-ms and Uhplc-qe-ms Have Different Advan-mentioning
confidence: 99%
“…Prostaglandin D2 can inhibit the development of gastric cancer [40]. Leukotriene D4 can aggravate gastric contraction and promote gastric acid secretion [41,42]. However, gastric pH increases during GPL and gastric cancer [43].…”
Section: Gc-tof-ms and Uhplc-qe-ms Have Different Advan-mentioning
confidence: 99%
“…Measurements of contraction of the isolated terminal ileal segments were performed according to the procedure described previously with modifications (Huang, 2011). Male Sprague-Dawley rats weighing 350-400 g, were sacrificed with CO 2 .…”
Section: Measurement Of Contraction Of Rat Isolated Ileummentioning
confidence: 99%
“…Leukotrienes have been implicated as mediators of acute synovial inflammation, cardiovascular disease, gastrointestinal tract disorders, allergic dermatologic conditions, and certain cancers. [1][2][3] The best characterization of the effects is for those within the respiratory tract, where they mediate airway hyperresponsiveness, mucus production, bronchoconstriction, increases in vascular permeability, and inflammation. 4 The importance of CysLTs in human respiratory medicine is supported by the clinical efficacy of the CysLT 1receptor antagonists, montelukast and zafirlukast, in asthmatic human patients.…”
mentioning
confidence: 99%